Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 2.9B | 3.1B | 3.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.2B | 2.2B | 2.4B | 2.7B |
Operating income | 784M | 403M | 492M | 652M |
Non operating interest income | ||||
Income | 525M | 176M | 274.8M | 138.5M |
Expense | 335M | 375M | 308.9M | 299.2M |
Other income expense | — | — | — | — |
Pretax income | 967M | 198M | 426.5M | 437.6M |
Tax provision | 47M | 105M | 127.3M | 87.2M |
Net income | 920M | 92M | 299.2M | 350.4M |
Basic EPS | 20.6 | -1 | 2.4 | 6.4 |
Diluted EPS | 20.6 | -1 | 2.4 | 6.4 |
Basic average shares | 42.5M | 42.5M | 42.5M | 42.5M |
Diluted average shares | 42.5M | 42.5M | 42.5M | 42.5M |
EBITDA | 1.6B | 898M | 1.1B | 1.1B |
Net income from continuing op. | 920M | 92M | 299.2M | 350.4M |
Minority interests | -43M | -134M | -197.6M | -79M |
Preferred stock dividends | 0 | 0 | 0 | 0 |